EP
BBC icon

Eudaimonia Partners’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Eudaimonia Partners’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-382
Closed -$20K – 456
2021
Q1 		$20K Buy
+382
New +$20.9K ﹤0.01% 934

Other funds holding BBC

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Eudaimonia Partners's BBC Position: Q2 2021 in Review

Eudaimonia Partners sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q2 2021, closing a stake of 382 shares — an estimated $20K sold.

Eudaimonia Partners first reported a position in BBC in Q1 2021 and held it in 1 quarter. The position peaked at $20K in Q1 2021. 19 funds tracked by Wall St. Rank hold BBC as of Q2 2021.

  • Eudaimonia Partners reported no remaining Virtus Biotech Clinical Trials ETF position as of Q2 2021 after selling out during the quarter.
  • Eudaimonia Partners sold 382 Virtus Biotech Clinical Trials ETF shares in Q2 2021, an estimated $20K.
  • Eudaimonia Partners first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2021 and held it in 1 quarter.
  • Eudaimonia Partners's Virtus Biotech Clinical Trials ETF position peaked at $20K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.